Geron Corporation Reports Second Quarter 2017 Financial Results
09 août 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2017. For the second quarter of...
Geron Announces Updates to Imetelstat Clinical Development
31 juil. 2017 19h00 HE
|
Geron Corporation
MENLO PARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced updates to the clinical development plans for IMerge and IMbark, the ongoing trials of the...
Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
09 mai 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...
Geron 2017 Annual Meeting of Stockholders to be Held on May 9
25 avr. 2017 07h30 HE
|
Geron Corporation
First Quarter 2017 Financial Results Expected Same Day MENLO PARK, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2017 Annual Meeting of Stockholders, on...
Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
10 avr. 2017 07h30 HE
|
Geron Corporation
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif.,...
Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
09 avr. 2017 08h00 HE
|
Geron Corporation
MENLO PARK, Calif., April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing...
Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
05 avr. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data...
Geron Announces Presentation at American Association for Cancer Research Annual Meeting
02 mars 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data...
Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
01 mars 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events. ...
Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
22 févr. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March...